Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas.
Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas.
Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1519-1529. doi: 10.1016/j.ijrobp.2021.03.039. Epub 2021 Mar 26.
To develop a noninvasive prognostic imaging biomarker related to hypoxia to predict SABR tumor control.
A total of 145 subcutaneous syngeneic Dunning prostate R3327-AT1 rat tumors were focally irradiated once using cone beam computed tomography guidance on a small animal irradiator at 225 kV. Various doses in the range of 0 to 100 Gy were administered, while rats breathed air or oxygen, and tumor control was assessed up to 200 days. Oxygen-sensitive magnetic resonance imaging (MRI) (T-weighted, ΔR, ΔR*) was applied to 79 of these tumors at 4.7 T to assess response to an oxygen gas breathing challenge on the day before irradiation as a probe of tumor hypoxia.
Increasing radiation dose in the range of 0 to 90 Gy enhanced tumor control of air-breathing rats with a TCD estimated at 59.6 ± 1.5 Gy. Control was significantly improved at some doses when rats breathed oxygen during irradiation (eg, 40 Gy; P < .05), and overall there was a modest left shift in the control curve: TCD(oxygen) = 53.1 ± 3.1 Gy (P < .05 vs air). Oxygen-sensitive MRI showed variable response to oxygen gas breathing challenge; the magnitude of T-weighted signal response (%ΔSI) allowed stratification of tumors in terms of local control at 40 Gy. Tumors showing %ΔSI >0.922 with O-gas breathing challenge showed significantly better control at 40 Gy during irradiation while breathing oxygen (75% vs 0%, P < .01). In addition, increased radiation dose (50 Gy) substantially overcame resistance, with 50% control for poorly oxygenated tumors. Stratification of dose-response curves based on %ΔSI >0.922 revealed different survival curves, with TCD = 36.2 ± 3.2 Gy for tumors responsive to oxygen gas breathing challenge; this was significantly less than the 54.7 ± 2.4 Gy for unresponsive tumors (P < .005), irrespective of the gas inhaled during tumor irradiation.
Oxygen-sensitive MRI allowed stratification of tumors in terms of local control at 40 Gy, indicating its use as a potential predictive imaging biomarker. Increasing dose to 50 Gy overcame radiation resistance attributable to hypoxia in 50% of tumors.
开发一种与缺氧相关的无创预后成像生物标志物,以预测 SABR 肿瘤控制。
共对 145 个皮下同源性 Dunning 前列腺 R3327-AT1 大鼠肿瘤进行了研究,使用小动物辐照仪在锥形束 CT 引导下对每个肿瘤进行单次聚焦照射。照射范围为 0 至 100 Gy,同时大鼠呼吸空气或氧气,并在 200 天内评估肿瘤控制情况。对其中 79 个肿瘤在 4.7 T 下进行了氧敏感磁共振成像(MRI)(T 加权,ΔR,ΔR*)检查,以评估辐照前一天吸氧时的氧合状态变化作为肿瘤缺氧的探针。
在 0 至 90 Gy 的范围内增加放射剂量,使呼吸空气的大鼠的肿瘤控制得到增强,TCD 估计值为 59.6±1.5 Gy。当大鼠在照射期间呼吸氧气时,在某些剂量下控制明显改善(例如 40 Gy;P<.05),并且整体上控制曲线向左略有偏移:TCD(氧气)=53.1±3.1 Gy(P<.05 与空气相比)。氧敏感 MRI 显示出对氧合气体呼吸挑战的不同反应;T 加权信号反应的幅度(%ΔSI)允许根据 40 Gy 时的局部控制对肿瘤进行分层。在呼吸氧气时接受 O 气体呼吸挑战的肿瘤显示出 %ΔSI>0.922,显示出显著更好的 40 Gy 时的控制率(75%对 0%,P<.01)。此外,增加剂量(50 Gy)可显著克服缺氧肿瘤的耐药性,对低氧肿瘤的控制率为 50%。基于 %ΔSI>0.922 对剂量反应曲线进行分层,显示出不同的生存曲线,对氧合气体呼吸挑战有反应的肿瘤的 TCD=36.2±3.2 Gy;这显著低于对氧合气体呼吸挑战无反应的肿瘤的 54.7±2.4 Gy(P<.005),而与肿瘤照射期间吸入的气体无关。
氧敏感 MRI 允许根据 40 Gy 时的局部控制对肿瘤进行分层,表明其可作为潜在的预测性成像生物标志物。将剂量增加到 50 Gy 可克服 50%肿瘤因缺氧引起的放射抵抗。